Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eldad Melamed

Showing results (11-20 of 120) with videos related to

Pageof 12
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|October 3, 2002
Focal dystonia as the presenting sign in Creutzfeldt-Jakob diseaseMark A Hellmann, Eldad Melamed
Apoptosis : an International Journal on Programmed Cell Death|March 27, 2010
Neurogenesis in the aged and neurodegenerative brainAdi Shruster, Eldad Melamed, Daniel Offen
Clinical Neuropharmacology|August 5, 2003
Waiting for ON: a major problem in patients with Parkinson disease and ON/OFF motor fluctuationsDoron Merims, Ruth Djaldetti, Eldad Melamed
Journal of Molecular Neuroscience : MN|January 19, 2005
Oxidative stress, induced by 6-hydroxydopamine, reduces proteasome activities in PC12 cells: implications for the pathogenesis of Parkinson's diseaseHanoch Elkon, Eldad Melamed, Daniel Offen
Neuroscience Letters|April 6, 2006
Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damageNirit Lev, Eldad Melamed, Daniel Offen
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Bent knees and tiptoeing: late manifestations of end-stage Parkinson's diseaseRuth Djaldetti, Mark Hellmann, Eldad Melamed
Movement Disorders : Official Journal of the Movement Disorder Society|February 19, 2009
Lesions outside the CNS in Parkinson's diseaseRuth Djaldetti, Nirit Lev, Eldad Melamed
The Israel Medical Association Journal : IMAJ|August 22, 2003
Neuroprotection in progressive brain disordersRuth Djaldetti, Nirit Lev, Eldad Melamed
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 27, 2003
Apoptosis and Parkinson's diseaseNirit Lev, Eldad Melamed, Daniel Offen
Expert Opinion on Biological Therapy|October 14, 2009
Bone-marrow-derived mesenchymal stem cell therapy for neurodegenerative diseasesOfer Sadan, Eldad Melamed, Daniel Offen
Pageof 12

Showing results (11-20 of 120) with videos related to

Sort By:
Pageof 12
Movement Disorders : Official Journal of the Movement Disorder Society|October 3, 2002
Focal dystonia as the presenting sign in Creutzfeldt-Jakob diseaseMark A Hellmann, Eldad Melamed
Apoptosis : an International Journal on Programmed Cell Death|March 27, 2010
Neurogenesis in the aged and neurodegenerative brainAdi Shruster, Eldad Melamed, Daniel Offen
Clinical Neuropharmacology|August 5, 2003
Waiting for ON: a major problem in patients with Parkinson disease and ON/OFF motor fluctuationsDoron Merims, Ruth Djaldetti, Eldad Melamed
Journal of Molecular Neuroscience : MN|January 19, 2005
Oxidative stress, induced by 6-hydroxydopamine, reduces proteasome activities in PC12 cells: implications for the pathogenesis of Parkinson's diseaseHanoch Elkon, Eldad Melamed, Daniel Offen
Neuroscience Letters|April 6, 2006
Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damageNirit Lev, Eldad Melamed, Daniel Offen
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Bent knees and tiptoeing: late manifestations of end-stage Parkinson's diseaseRuth Djaldetti, Mark Hellmann, Eldad Melamed
Movement Disorders : Official Journal of the Movement Disorder Society|February 19, 2009
Lesions outside the CNS in Parkinson's diseaseRuth Djaldetti, Nirit Lev, Eldad Melamed
The Israel Medical Association Journal : IMAJ|August 22, 2003
Neuroprotection in progressive brain disordersRuth Djaldetti, Nirit Lev, Eldad Melamed
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 27, 2003
Apoptosis and Parkinson's diseaseNirit Lev, Eldad Melamed, Daniel Offen
Expert Opinion on Biological Therapy|October 14, 2009
Bone-marrow-derived mesenchymal stem cell therapy for neurodegenerative diseasesOfer Sadan, Eldad Melamed, Daniel Offen
Pageof 12